From Our Partners
Wednesday, June 29, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

Congressionally Directed Medical Research FY2014

by Global Biodefense Staff
March 10, 2014
CDMRP - Congressionally Directed Medical Research Programs

The Department of Defense office of Congressionally Directed Medical Research Programs (CDMRP) has detailed focus efforts and allocations for FY 2014 research projects. 

Comprehensive Program Announcements will be released during 2014. The Program Announcements will include detailed descriptions of funding mechanisms, evaluation criteria, submission requirements, and deadlines. Each Program Announcement may be downloaded from the Grants.gov website upon its release. 

The anticipated projects for FY2014 include:

  • Gulf War Illness Research Program – $20.0 million
  • Tuberous Sclerosis Complex Research Program – $6.0 million
  • Amyotrophic Lateral Sclerosis Research Program – $7.5 million
  • Autism Research Program – $6.0 million
  • Bone Marrow Failure Research Program – $3.2 million
  • Breast Cancer Research Program – $120.0 million
  • Duchenne Muscular Dystrophy Research Program – $3.2 million
  • Lung Cancer Research Program – $10.5 million
  • Multiple Sclerosis Research Program – $5.0 million
  • Neurofibromatosis Research Program – $15.0 million
  • Ovarian Cancer Research Program – $20.0 million
  • Peer Reviewed Cancer Research Program – $25.0 million
  • Peer Reviewed Medical Research Program – $200.0 million
  • Peer Reviewed Orthopaedic Research Program – $30.0 million
  • Prostate Cancer Research Program – $80.0 million
  • Spinal Cord Injury Research Program – $30.0 million

The CDMRP finds and funds the best research through a competitive, two-tier application review process to target innovative research approaches and encourage high-impact advancements.  The CDMRP maintains a disease-specific focus with funds directed toward most critical needs.

From Our Partners

Related Posts

NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity
Biosecurity

U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity

April 13, 2022
NIAID Funding Available for Biocontainment Facility Improvements
Biosecurity

NIAID Funding Available for Biocontainment Facility Improvements

April 8, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC